Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-10

FDA Approved: SPINRAZA — Supplemental Application (Biogen Inc.)

View source ↗

Summary

The FDA approved Biogen's supplemental application for Spinraza (nusinersen).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinraza (nusinersen)

Snippet

SUPPL AP for SPINRAZA (NUSINERSEN)